Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Report 2026

Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Overview

• Perfusion Bioreactor With Artificial Intelligence (AI) Control market size has reached to $1.88 billion in 2025 • Expected to grow to $4.85 billion in 2030 at a compound annual growth rate (CAGR) of 20.8% • Growth Driver: Rising Adoption Of Personalized Medicine Driving The Market Growth Due To Enhanced Efficiency And Safety In Individualized Treatments • Market Trend: Advancements In AI-Driven Real-Time Bioprocess Monitoring For Optimized Biomanufacturing • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Perfusion Bioreactor With Artificial Intelligence (AI) Control Market?

Perfusion bioreactor with artificial intelligence (AI) control is a bioreactor system for continuous cell culture that supplies fresh media and removes waste. AI monitors key parameters and dynamically adjusts conditions to maximize productivity, consistency, and efficiency in biologics or cell-based product manufacturing. The main product types of perfusion bioreactors with artificial intelligence (AI) control are single-use perfusion bioreactors and multi-use perfusion bioreactors. Single-use perfusion bioreactors are disposable systems for continuous cell culture that enhance scalability and reduce contamination in biomanufacturing. Artificial intelligence (AI) control features include predictive analytics, process optimization, real-time monitoring, automated feedback control, and others. These bioreactors are applied in cell therapy, monoclonal antibody production, vaccine manufacturing, stem cell research, and others, serving end-users including biopharmaceutical companies, academic and research institutes, contract manufacturing organizations, and others.

What Is The Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Growth Forecast?

The perfusion bioreactor with artificial intelligence (ai) control market size is expected to see exponential growth in the next few years. It will grow to $4.85 billion in 2030 at a compound annual growth rate (CAGR) of 20.8%. The growth in the forecast period can be attributed to increasing investments in ai-enabled biomanufacturing, rising demand for cell and gene therapies, expansion of continuous manufacturing adoption, growing focus on process scalability and efficiency, increased regulatory acceptance of advanced bioprocess technologies. Major trends in the forecast period include increasing adoption of ai-driven perfusion control systems, rising use of continuous cell culture platforms, growing demand for single-use perfusion bioreactors, expansion of real-time process optimization capabilities, enhanced focus on yield and process consistency.

Global Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Segmentation

1) By Product Type: Single Use Perfusion Bioreactors, Multi-Use Perfusion Bioreactors 2) By Artificial Intelligence (AI) Control Type: Predictive Analytics, Process Optimization, Real-Time Monitoring, Automated Feedback Control, Other Artificial Intelligence (AI) Control Types 3) By Application: Cell Therapy, Monoclonal Antibody Production, Vaccine Manufacturing, Stem Cell Research, Other Applications 4) By End-User: Biopharmaceutical Companies, Academic And Research Institutes, Contract Manufacturing Organizations, Other End-Users Subsegments: 1) By Single-Use Perfusion Bioreactors: Disposable Bag Bioreactors, Modular Single-Chamber Bioreactors, Pre-Sterilized Single-Vessel Bioreactors 2) By Multi-Use Perfusion Bioreactors: Stainless Steel Bioreactors, Glass Bioreactors, Multi-Vessel Continuous Culture Systems

What Is The Driver Of The Perfusion Bioreactor With Artificial Intelligence (AI) Control Market?

The increasing prevalence of personalized medicine is expected to propel the growth of the perfusion bioreactor with artificial intelligence (AI) control market going forward. Personalized medicine is the approach of customizing medical treatment to an individual’s genetic, molecular, and clinical characteristics for more precise and effective care. Personalized medicine is increasing due to advances in genomics, allowing treatments tailored to a patient’s unique genetic profile for greater effectiveness and safety. Perfusion bioreactors with AI control support personalized medicine by enabling precise, continuous production of patient-specific cells, such as stem cells or engineered tissues, under highly controlled conditions. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. The newly approved personalized treatments for 2023 also include seven cancer drugs and three for other diseases and conditions. Therefore, the increasing prevalence of personalized medicine is driving the growth of the perfusion bioreactor with artificial intelligence (AI) control industry.

Key Players In The Global Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

Major companies operating in the perfusion bioreactor with artificial intelligence (ai) control market are Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG., Danaher Corporation, Sartorius Aktiengesellschaft, Getinge AB., WuXi Biologics Inc., Eppendorf Aktiengesellschaft, ABEC Inc., Catalyx.ai, PBS Biotech Inc., Cytovance Biologics, Culture Biosciences Inc., Esco Lifesciences Group Ltd., Cell Culture Company GmbH, Synthecon Inc., OmniBRx Biotechnologies Inc., ProlifeCell Inc., Sciperio Ltd., The Cultivated B Ltd.

Global Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Trends and Insights

Major companies operating in the perfusion bioreactor with artificial intelligence (AI) control market are focusing on developing advanced approaches, such as AI-enhanced real-time bioprocess monitoring to optimize cell culture performance, improve product yield, and reduce operational costs in biopharmaceutical manufacturing. AI-enhanced real-time bioprocess monitoring refers to the use of artificial intelligence algorithms to continuously analyze bioreactor data, enabling real-time insights, predictive adjustments, and optimization of cell growth and product quality during biomanufacturing. For instance, in February 2025, The Cultivated B GmbH, a Germany-based biotechnology company, launched AI-driven multi-channel biosensors designed to enhance real-time monitoring of bioreactors in cell culture and fermentation processes. These biosensors provide continuous high-resolution data analytics, enabling bioprocess engineers to track growth and metabolism with exceptional sensitivity, detecting molecules at sub-picomolar levels such as glucose, amino acids, and lactic acid. The AI integration offers real-time insights and recommendations to optimize media formulation, improve measurement reliability, reduce contamination risk by eliminating manual sampling, and accelerate product development for applications in pharmaceuticals, biologics, food biotechnology, waste upcycling, and alternative protein production.

What Are Latest Mergers And Acquisitions In The Perfusion Bioreactor With Artificial Intelligence (AI) Control Market?

In August 2025, Culture Biosciences Inc., a US-based biotechnology company, partnered with Cytiva Bioscience Holding Ltd. to enhance digital bioprocessing solutions. This collaboration aims to accelerate and de-risk upstream bioprocess development by delivering scalable, cloud-connected, and digitally integrated bioreactor systems that support faster, more predictable therapeutic production from benchtop to commercial scale. Cytiva Bioscience Holding Ltd. is a US-based biotechnology company that provides a perfusion bioreactor with artificial intelligence (AI) control.

Regional Insights

North America was the largest region in the perfusion bioreactor with artificial intelligence (AI) control market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Perfusion Bioreactor With Artificial Intelligence (AI) Control Market?

The perfusion bioreactor with artificial intelligence (AI) control market consists of revenues earned by entities by providing services such as cell culture management, nutrient and waste regulation, AI-driven process control, performance optimization, and automated data analytics. The market value includes the value of related goods sold by the service provider or included within the service offering. The perfusion bioreactor with artificial intelligence (AI) control market includes sales of automated perfusion bioreactor systems, hybrid perfusion bioreactors, and AI-integrated bench-scale perfusion bioreactors. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Report 2026?

The perfusion bioreactor with artificial intelligence (ai) control market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the perfusion bioreactor with artificial intelligence (ai) control industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.